Search
for
Sort by
Research 181–210 of 1000+
- Pathomechanisms of immune-mediated alopecia
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Under Development JAK Inhibitors for Dermatologic Diseases
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Janus kinase inhibitors: An innovative treatment for alopecia areata
- Unraveling the secret life of the hair follicle: from fungi to innovative hair loss therapies
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- What’s New in Hair Loss
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Alopecia universalis. Partial response to tofacitinib
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches